Regeneus has announced that the first patient has been enrolled and treated in a clinical trial of the company's autologous tumour vaccine, RGSH4K. [ + ]

Prime Minister Malcolm Turnbull has announced that Dr Alan Finkel AO will be Australia's next Chief Scientist. [ + ]

Scientists from The University of Queensland have discovered two new microorganisms which are said to play an unknown role in greenhouse gas emissions and consumption. [ + ]

TGR BioSciences has announced a European licence agreement with Prime Diagnostics — a developer of high-quality diagnostics, technologies and services for the agricultural sector. [ + ]

Minomic International will next year launch a human study of its monoclonal antibody technology as an imaging agent to detect prostate, pancreatic and bladder cancers. [ + ]

The 2015 Prime Minister's Prizes for Science were awarded on 21 October at a celebratory dinner held at Parliament House. [ + ]

Medlab Clinical has been granted ethics approval to begin two separate human trials using its nanotechnology delivery platform, NanoCelle. The platform, previously developed for cannabis research, converts pharmaceuticals into nanoparticle form. [ + ]

Oxford Nanopore Technologies has developed the MinION, a handheld device that works by detecting individual DNA bases that pass through a nanopore. [ + ]

Australian scientists have contributed to the worldwide effort of redefining the international unit of temperature: the kelvin. [ + ]

JDRF has announced a new clinical trial to slow the development of newly diagnosed type 1 diabetes in children. The trial will test a new application of an existing drug currently approved for use in children with juvenile arthritis. [ + ]

Months after the phenomenon known as 'The Dress' hit the internet, neuroscientists have demonstrated that the optical illusion is linked to specific brain activation patterns. [ + ]

The managing director of Olympus Australia and New Zealand, James Bowe, has made his vision for the company clear, claiming that success is driven by customer relationships. [ + ]

Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities. [ + ]

Pharmaceutical company Merck has announced a relaunch of its brand identity in order to reflect its transformation into a global science and technology company. [ + ]

Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy. [ + ]